Ad5CMV-NIS

N/A

Report date: 2023/10/26 16:19:23

Base Information

Drug NameAd5CMV-NIS
Drug Alias Namesodium iodide symporter adenoviral gene therapyAd5CMV-NIS
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionSodium/iodide cotransporter stimulants
TargetsSodium/iodide cotransporter
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMayo Clinic
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A